Pregnant rats treated with a serotonin precursor have reduced fetal weight and lower plasma volume and kallikrein levels

Hypertension

Volumn 50, Issue 4, 2007, Pages 773-779

  Salas, Sofía P ^a   Giacaman, Andrea ^a   Romero, William ^a   Downey, Patricio ^a   Aranda, Eduardo ^a   Mezzano, Diego ^a   Vío, Carlos P ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Acute kidney failure; Aldosterone; Experimental models; Kallikrein; Plasma volume; Preeclampsia pregnancy; Serotonin

Indexed keywords

5 HYDROXYTRYPTOPHAN; ALDOSTERONE; CREATININE; KALLIKREIN; KETANSERIN; SEROTONIN; SEROTONIN 2 ANTAGONIST;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; FETUS WEIGHT; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; MORPHOLOGY; NONHUMAN; PLACENTA WEIGHT; PLASMA VOLUME; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; SYSTOLIC BLOOD PRESSURE; URINALYSIS; VASCULAR RESISTANCE;

5-HYDROXYTRYPTOPHAN; ALDOSTERONE; ANIMALS; BLOOD PRESSURE; CREATININE; DISEASE MODELS, ANIMAL; FEMALE; FETAL WEIGHT; KALLIKREINS; KETANSERIN; PLASMA VOLUME; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY, ANIMAL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT2;

EID: 34548837178     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.094540     Document Type: Conference Paper

References (41)

1. Schrier RW, Briner VA. Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia. Obstet Gynecol. 1991;77:632-639.
2. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256:H1060-H1065.
3. Phippard AF, Horvath JS, Glynn EM, Garner MG, Fletcher PJ, Duggin GG, Tiller DJ. Circulatory adaptation to pregnancyorserial studies of hemodynamics, blood volume, renin and aldosterone in the baboon (Papio hamadryas). J Hypertens. 1986;4:773-779.
4. Salas SP, Rosso P, Espinoza R, Robert JA, Valdés G, Donoso E. Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation. Obstet Gynecol. 1993;81:1029-1033.
5. Salas SP, Rosso P. Plasma volume, renal function, and hormonal levels in pregnant women with idiopathic fetal growth restriction or preeclampsia. Hypertens Pregnancy. 1998;17:69-79.
6. Middelkoop CM, Dekker GA, Kraayenbrink AA, Popp-Snijders C. Platelet-poor plasma serotonin in normal and preeclamptic pregnancy. Clin Chem. 1993;39:1675-1678.
7. Abboud HE, Dousa TP. Renal metabolism and actions of histamine and serotonin. Miner Electrolyte Metab. 1983;9:246-259.
8. Karlsson C, Bodelsson G, Bodelsson M, Stjernquist M. 5-Hydroxytryptamine contracts human uterine artery smooth muscle predominantly via 5-HT2 receptors. Hum Reprod. 1997;12:361-367.
9. Cruz MA, Gallardo V, Miguel P, Carrasco G, Gonzalez C. Serotonin-induced vasoconstriction is mediated by thromboxane release and action in the human fetal-placental circulation. Placenta. 1997;18:197-204.
10. González C, Cruz MA, Gallardo V, Albornoz J, Bravo PI. Serotonin-induced vasoconstriction in human placental chorionic veins: interaction with prostaglandin F2α. Gynecol Obstet Invest. 1993;35:86-90.
11. Salas SP, Altermatt F, Campos M, Giacaman A, Rosso P. Effects of long-term nitric oxide synthesis inhibition on plasma volume expansion and fetal growth in the pregnant rat. Hypertension. 1995;26:1019-1023.
12. Salas SP, Vuletin JF, Giacaman A, Rosso P, Vío CP. Long-term nitric oxide synthase inhibition in rat pregnancy reduced renal kallikrein. Hypertension. 1999;34:865-871.
13. Basile DP, Fredrich K, Alausa M, Vio CP, Liang M, Rieder MR, Greene AS, Cowley AW Jr. Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol. 2005;288:F953-F963.
14. Salas SP, Roblero JS, Croxatto HR, Valdés G. Urinary kallikrein activity during rat pregnancy. Arch Biol Med Exp. 1987;20:305-309.
15. Kumar AM, Kumar M, Deepika K, Fernandez JB, Eisdorfer C. A modified HPLC technique for simultaneous measurement of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in cerebrospinal fluid, platelet and plasma. Life Sci. 1990;47:1751-1759.
16. Masilamani S, Hobbs GR, Baylis C. The acute pressure natriuresis response blunted and the blood pressure response reset in the normal pregnant rat. Am J Obstet Gynecol. 1998;179:486-491.
17. Atherton JC, Green R. Renal function in pregnancy. Clin Sci (Lond). 1983;65:449-453.
18. Conrad KP. Mechanisms of renal vasodilation and hyperfiltration during pregnancy. J Soc Gynecol Investig. 2004;11:438-448.
19. Waugh D, Pearl MJ. Serotonin-induced acute nephrosis and renal cortical necrosis in rats. A morphologic study with pregnancy correlations. Am J Pathol. 1960;36:431-455.
20. Bolte AC, van Geijn HP, Dekker GA. Pathophysiology of preeclampsia and the role of serotonin. Eur J Obstet Gynecol Reprod Biol. 2001;95:12-21.
21. Murray SM. The morphology of serotonin-induced renal lesions in the rat. J Pathol. 1979;128:203-211.
22. Endlich K, Kuhn R, Steinhausen M. Visualization of serotonin effects on renal vessels of rats. Kidney Int. 1993;43:314-323.
23. Barron WM. Volume homeostasis during pregnancy in the rat. Am J Kid Dis. 1987;9:296-302.
24. Valdés G, Salas SP, Foradori AC, Gormaz G, Croxatto HR. The neurogenic response to 55-degree head-up tilt in normal pregnant women. Hypertension. 1986;8(suppl I):I-161-I-164.
25. August P, Lenz T, Ales KL, Druzin ML, Edersheim TG, Hutson JM, Müller FB, Laragh JH, Sealy JE. Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol. 1990;163:1612-1621.
26. Salas SP, Giacaman A, Vío CP. Pregnant rats with 5/6 nephrectomy have normal volume expansion despite lower renin and kallikrein. Hypertension. 2003;42:744-748.
27. Vío CP, Loyola S, Velarde V. Localization of components of the kallikrein-kinin system in the kidney: relation to renal function. State of the art lecture. Hypertension. 1992;19(suppl 2):10-16.
28. Jaffa AA, Vío CP, Silva RH, Vavrek RJ, Stewart JM, Rust PF. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat. J Clin Invest. 1992;89:1460-1468.
29. Wa TC, Burns NJ, Williams BC, Freestone S, Lee MR. Blood and urine 5-hydroxytryptophan and 5-hydroxytryptamine levels after administration of two 5-hydroxytryptamine precursors in normal man. Br J Clin Pharmacol. 1995;39:327-329.
30. Duvekot JJ, Cheriex EC, Pieters FAA, Menheere PPCA, Schouten HJA, Peeters LLH. Maternal volume homeostasis in early pregnancy in relation to fetal growth restriction. Obstet Gynecol. 1995;85:361-367.
31. Salas SP, Marshall G, Gutierrez BL, Rosso P. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension. 2006;47:203-208.
32. Gonzalez C, Cruz MA, Sepulveda WH, Rudolph MI. Effects of serotonin on vascular tone of isolated human placental chorionic veins. Gynecol Obstet Invest. 1990;29:88-91.
33. Dong YL, Green KE, Vegiragu S, Hankins GD, Martin E, Chauhan M, Thota C, Yallampalli C. Evidence for decreased calcitonin gene-related peptide (CGRP) receptors and compromised responsiveness to CGRP of fetoplacental vessels in preeclamptic pregnancies. J Clin Endocrinol Metab. 2005;90:2336-2343.
34. Vesela J, Rehak P, Mihalik J, Czikkova S, Pokorny J, Koppel J. Expression of serotonin receptors in mouse oocytes and preimplantation embryos. Physiol Res. 2003;52:223-228.
35. Sonier B, Lavigne C, Arseneault M, Ouellette R, Vaillancourt C. Expression of the 5-HT2A serotoninergic receptor in human placenta and choriocarcinoma cells: mitogenic implications of serotonin. Placenta. 2005;26:484-490.
36. Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslen B, Marsal K, Hansson SR. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta. 2004;25:518-529.
37. Carrasco G, Cruz MA, Gallardo V, Miguel P, Lagos M, Gonzalez C. Plasma and platelet concentration and platelet uptake of serotonin in normal and pre-eclamptic pregnancies. Life Sci. 1998;62:1323-1332.
38. Sivasubramaniam SD, Finch CC, Billett MA, Baker PN, Billett EE. Monoamine oxidase expression and activity in human placentae from pre-eclamptic and normotensive pregnancies. Placenta. 2002;23:163-171.
39. Sharkey LC, McCune SA, Yuan O, Lange C, Fray J. Spontaneous pregnancy-induced hypertension and intrauterine growth restriction in rats. Am J Hypertens. 2001;14:1058-1066.
40. Bolte AC, van Eyck J, Kanhai HH, Bruinse HW, van Geijn HP, Dekker GA. Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome. Am J Obstet Gynecol. 1999;180:371-377.
41. Bolte AC, van Eyck J, Gaffar SF, van Geijn HP, Dekker GA. Ketanserin for the treatment of preeclampsia. J Perinat Med. 2001;29:14-22.